Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C

Background and Aim:  The incidence of hepatocellular carcinoma (HCC) has increased in Australia in recent decades, a large and growing proportion of which occurs among a population chronically infected with hepatitis B virus (HBV) or hepatitis C virus (HCV). However, risk factors for HCC among these high‐risk groups require further characterization.

[1]  M. Tong,et al.  Chronic hepatitis B and hepatocellular carcinoma. , 2010, Clinics in liver disease.

[2]  M. Sherman.  Hepatocellular carcinoma: New and emerging risks. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[3]  J. Kaldor,et al.  The epidemiology of hepatitis C in Australia: Notifications, treatment uptake and liver transplantations, 1997–2006 , 2009, Journal of gastroenterology and hepatology.

[4]  K. Howard,et al.  Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening. , 2009, Journal of hepatology.

[5]  N. Probst-Hensch,et al.  Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma , 2008, Infectious Agents and Cancer.

[6]  G. Dore,et al.  Estimates and projections of hepatitis B‐related hepatocellular carcinoma in Australia among people born in Asia‐Pacific countries , 2008, Journal of gastroenterology and hepatology.

[7]  Ching-Lung Lai,et al.  Natural history of hepatitis-related hepatocellular carcinoma. , 2008, World journal of gastroenterology.

[8]  J. Kaldor,et al.  Liver cancer and hepatitis B and C in New South Wales, 1990–2002: a linkage study , 2007, Australian and New Zealand journal of public health.

[9]  H. El‐Serag.  Epidemiology of hepatocellular carcinoma in USA , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[10]  M. Levy,et al.  Hepatocellular carcinoma in Sydney South West: late symptomatic presentation and poor outcome for most , 2007, Internal medicine journal.

[11]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[12]  J. Hiatt,et al.  Chronic Viral Hepatitis and Hepatocellular Carcinoma , 2007, World Journal of Surgery.

[13]  M. Kew.  Interaction between hepatitis B and C viruses in hepatocellular carcinogenesis , 2006, Journal of viral hepatitis.

[14]  M. Bailey,et al.  Survival in hepatocellular carcinoma: Impact of screening and etiology of liver disease , 2005, Journal of gastroenterology and hepatology.

[15]  R O Morgan,et al.  Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study , 2005, Gut.

[16]  K. McGlynn,et al.  Epidemiology and natural history of hepatocellular carcinoma. , 2005, Best practice & research. Clinical gastroenterology.

[17]  Shiyuan Liu,et al.  A meta-analysis of case–control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China , 2005, British Journal of Cancer.

[18]  Josepa Ribes,et al.  Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.

[19]  K. McGlynn,et al.  Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. , 2004, Gastroenterology.

[20]  A. Whittemore,et al.  Role of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  Jian-Min Yuan,et al.  Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. , 2004, Cancer.

[22]  J. Kaldor,et al.  Estimates of chronic hepatitis B virus infection in Australia, 2000 , 2004, Australian and New Zealand Journal of Public Health.

[23]  Zhao-You Tang,et al.  Randomized controlled trial of screening for hepatocellular carcinoma , 2004, Journal of Cancer Research and Clinical Oncology.

[24]  Ching‐lung Lai.  Therapeutic advances in chronic hepatitis B , 2004, Journal of gastroenterology and hepatology.

[25]  H. El‐Serag,et al.  Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. , 2004, Gastroenterology.

[26]  S. Porru,et al.  Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. , 2002, American journal of epidemiology.

[27]  D. Parkin,et al.  Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.

[28]  J. Kaldor,et al.  Primary hepatocellular carcinoma in Australia, 1978‐1997: increasing incidence and mortality , 2000, The Medical journal of Australia.

[29]  P. V. Rao,et al.  Applied Survival Analysis: Regression Modeling of Time to Event Data , 2000 .

[30]  C. Chu.  Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma , 2000, Journal of gastroenterology and hepatology.

[31]  Yasuyuki Arakawa,et al.  Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan , 1999, Annals of Internal Medicine.

[32]  Xiao Wang,et al.  A case-control study of risk factors for hepatocellular carcinoma in Henan, China. , 1998, The American journal of tropical medicine and hygiene.

[33]  P Boffetta,et al.  A meta‐analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma , 1998, International journal of cancer.

[34]  Chien-Jen Chen,et al.  Epidemiological characteristics and risk factors of hepatocellular carcinoma , 1997, Journal of gastroenterology and hepatology.

[35]  J. Ferlay,et al.  Cancer and infection: estimates of the attributable fraction in 1990. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[36]  C. J. Chen,et al.  Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. , 1997, American journal of epidemiology.

[37]  M. Colombo,et al.  Epidemiology of hepatocellular carcinoma. , 1995, The Italian journal of gastroenterology.

[38]  C. J. Chen,et al.  Hepatitis B and C viruses in the development of hepatocellular carcinoma. , 1994, Critical reviews in oncology/hematology.

[39]  P. Grambsch,et al.  Proportional hazards tests and diagnostics based on weighted residuals , 1994 .

[40]  K. Chayama,et al.  A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis , 1993, Hepatology.

[41]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[42]  A. Lok,et al.  RISK FACTORS FOR HEPATOCELLULAR CARCINOMA , 1985, The Lancet.

[43]  Lu-Yu Hwang,et al.  HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS A Prospective Study of 22 707 Men in Taiwan , 1981, The Lancet.

[44]  N. Wood,et al.  Estimates of chronic hepatitis B virus infection in the Northern Territory. , 2005, Communicable diseases intelligence quarterly report.

[45]  F. X. Bosch,et al.  Epidemiology of Primary Liver Cancer , 1999, Seminars in liver disease.

[46]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.